Wed.Jul 27, 2022

article thumbnail

Antimicrobial Stewardship in the United kingdom: Perspective From A Pharmacist At A Bone & Joint Hospital

IDStewardship

In this article antimicrobial stewardship in the United Kingdom is discussed. Interview with: Tariq Azamgarhi, MRPharmS, PGDip Clin Pharm, PG CEPIP. Interview by: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP. Article posted 1 August 2022. Antibiotic use and resistance varies geographically, but across the world antimicrobial stewardship (AS) and antimicrobial stewardship programs (ASPs) can serve as critical towards supporting safe and appropriate antimicrobial drug use.

Hospitals 147
article thumbnail

Summertime Medication Sun Safety Tips

Pharmacy Times

With the vast number of drugs that can induce photosensitivity, patients taking any of these medications should receive safety counseling, especially during the summer months.

132
132
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Personalizing the Cancer Patient Journey

Pharma Marketing Network

In the first two weeks after a cancer diagnosis, there are likely dozens of doctor’s visits, tests, consultations, and decision points. The patient care team supplies an abundance of information, although sifting through brochures and online resources can be daunting for the patient and their caregiver. Adhering to regulatory guidelines is an important step pharma takes to ensure that promotional medical materials contain balanced information that is accurate and relevant. 1 The marketer’s goal

article thumbnail

Pharmacist-Based Deprescribing Reduced Prescription, Cumulative Use of High-Risk Drugs in Older Adults

Pharmacy Times

Two pharmacist-based deprescribing models reduced the use and prescription of anticholinergics, a high-risk drug in older adults, providing evidence for the use of pharmacists is practitioners of deprescribing.

123
123
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Pfizer takes COVID jab with ‘enhanced’ spike protein into phase 2

pharmaphorum

Pfizer and BioNTech have started a mid-stage trial of a new version of the COVID-19 vaccine based on a version of the spike protein that they hope will offer greater and broader protection against SARS-CoV-2 variants. The vaccine, codenamed BNT162b5, codes for “enhanced” prefusion spike proteins from the original wild-type strain of the virus and the Omicron variant that are designed to increase “the magnitude and breadth of the immune response.” The phase 2 trial will te

Vaccines 122
article thumbnail

COVID-19 Infection in Children Associated with Post-COVID Conditions, Including Fatigue, Weakness

Pharmacy Times

SARS-CoV-2 infection was associated with post-COVID-19 conditions for children, with associated risk factors including length of hospitalization, number of acute symptoms, and older age.

Hospitals 123

More Trending

article thumbnail

Newly Identified Clinical Symptoms of Monkeypox Similar to Common STI Symptoms

Pharmacy Times

Researchers suggest that the current case definition of monkeypox be broadened to include genital lesions and sores on the mouth or anus as symptoms to prevent misdiagnoses.

123
123
article thumbnail

FDA grants priority review for Biogen’s tofersen to treat ALS

Pharmaceutical Technology

The US Food and Drug Administration (FDA) has granted priority review for Biogen ’s New Drug Application (NDA) for investigational drug, tofersen, to treat superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis (ALS). A decision from the regulatory agency on approval for the drug is anticipated on 25 January next year. The FDA also plans to hold an advisory committee meeting for the NDA.

FDA 98
article thumbnail

Additional COVID-19 Booster Dose Strengthens Waning Immunity Against Omicron Subvariants

Pharmacy Times

Study findings coincide with the US government considering recommendations of a second COVID-19 booster dose for adults under 50 years of age.

article thumbnail

Healthware forms new medical communications division

pharmaphorum

Health innovation and technology specialist Healthware Group has added another element to its business with the launch of a dedicated medical communications and education division. The new unit – dubbed Healthware MedComms – promises to take a fresh approach to medical communications that meets “the always-on, audience-centric, evidence-driven demands of today’s modern clinical environment.” It adds to Healthware’s fast-growing presence in the healthcare communications se

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

FDA Accepts sBLA of Trastuzumab Deruxtecan for Treatment of Individuals With HER2-Low Breast Cancer

Pharmacy Times

Trastuzumab deruxtecan is an engineered HER2-directed antibody drug conjugate being jointly developed and commercialized by AstraZeneca and Daiichi Sankyo.

FDA 123
article thumbnail

Global comparator data signal “alarm bells” for UK Government, says APBI

pharmaphorum

Latest UK Life Sciences Competitive Indicators “ought to ring alarm bells across Government,” says ABPI. Despite the UK’s potential as an international life sciences leader, it lags many competitors in a number of key metrics, including access to new medicines and global share of clinical trial recruitment. Richard Torbett, chief executive at the Association of the British Pharmaceutical Industry (ABPI) said Life Sciences Competitive Indicators (LSCI) data published last week “ought to ring alar

article thumbnail

FDA to Review Supplemental Biologics License Application for Another Adalimumab Biosimilar

Pharmacy Times

FDA accepts supplemental Biologics License Application for Hyrimoz HCF, a biosimilar with the same indications as adalimumab (Humira).

FDA 123
article thumbnail

Has Data Science Caught up with Science Data: Q&A with Mike McKee, President of Dotmatics

PharmExec

Has data science finally reached a level playing field with all of the science data being uncovered in the make, test, decide innovation cycle?

88
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

6 Major Trends Boosting the Telemedicine Market in Health Care

Pharmacy Times

The number of medical visits carried out via telehealth grew from 840,000 in 2019 to 52.7 million in 2020.

177
177
article thumbnail

What’s next for Biogen? Here’s what executives are saying

PharmaVoice

A trickling launch for Aduhelm and a middling earnings report give Biogen executives a lot to talk about. Is there hope?

96
article thumbnail

How Pharmacists Can Have Their Voices Heard in Public Policy

Pharmacy Times

We have to have this one voice that we've been talking about, this one consistent message.

132
132
article thumbnail

AmerisourceBergen aims to make digital therapeutics access easier

pharmaphorum

Pharma distributor AmerisourceBergen is working on a platform to make access to digital therapeutics (DTx) easier in the US by providing a unified system for ordering, dispensing and fulfilment. The new system – called DTx Connect – aims to help physicians order both prescription and non-prescription DTx and diagnostics through a simple interface, and monitor shipping and delivery to their patients.

article thumbnail

Tip of the Week: Broaden Your View of Value Creation for Services

Pharmacy Times

It is important to step back and see value creation for services from a broader and more fundamental perspective than the individual, daily tasks in the pharmacy.

65
article thumbnail

Woman of the Week: Applied BioMath's Katie Williams

PharmaVoice

The 2022 president of Women in Bio is equal parts math and gender parity evangelist.

98
article thumbnail

Oncology Overview: Pirtobrutinib—A New BTK Inhibitor

Pharmacy Times

Pirtobrutinib is under investigation in clinical trials in patients with CLL/small lymphocytic lymphoma, mantle cell lymphoma, and non-Hodgkin lymphoma.

65
article thumbnail

Novavax Covid-19 vaccine gets Australian TGA approval for adolescents

Pharmaceutical Technology

Novavax has r eceived expanded approval for provisional registration from the Australian Therapeutic Goods Agency (TGA) for its Covid-19 vaccine, Nuvaxovid (NVX-CoV2373), for use in adolescents aged 12 to 17 years. Nuvaxovid is indicated for active immunisation for the prevention of Covid-19 in individuals of this age group. It is the first protein-based vaccine to be offered in Australia for adolescents aged 12 to 17 years.

article thumbnail

Daily Medication Pearl: Angiotensin II (Giapreza) Injection

Pharmacy Times

Angiotensin II (Giapreza) is a vasoconstrictor to increase blood pressure in adults with septic or other distributive shock.

65
article thumbnail

Accelerating Market Access with Data-Driven Payer Engagement

PharmExec

Using data visualizations to improve access to payers.

96
article thumbnail

Examples of Advocacy in the Community for Public Policy Issues

Pharmacy Times

You just need to tell your story and be genuine and be real, and it makes such a difference.

73
article thumbnail

Low-Cost Ways To Get New Pharmacy Patients

DiversifyRx

Getting new pharmacy patients doesn’t have to be expensive. Patients are the lifeblood of pharmacies. Whether you focus on dispensing prescriptions, selling supplements, or fixing hormones, you need pharmacy patients. . I am a huge fan of guerilla-style marketing. Over the years, I have perfected many tactics that work well for independent pharmacies as we want our patients to come to us, IRL (in real life!).

article thumbnail

Quviviq From Idorsia Pharmaceuticals

Pharmacy Times

The FDA has approved daridorexant (Quviviq; Idorsia Pharmaceuticals, US Inc) to treat adults with insomnia.

FDA 65
article thumbnail

Drug Shortages Plague The Pharmacy— Yet Are Often Overlooked By The Public

The Happy PharmD

There’s a baby food shortage occurring in the United States. Imagine, first toilet paper and then baby food! I guess it’s a good thing that a shortage never occurred with drugs. Of course, it has. I started putting together a weekly list of drug shortages when I was in my first hospital in the early 1980s. The American Society of Health-System Pharmacists (ASHP) has an up-to-date list on its website.

article thumbnail

Using RWD to Unlock Better Outcomes for IBD and NASH Patients

PharmExec

Thu, Jul 28, 2022 11:00 AM EDT With no cure for IBD and other conditions, like NASH, treatments are aimed at reducing symptoms and preventing complications. Real-world data and AI applications provide a unique opportunity to better understand disease progression, treatment effectiveness, and outcomes.

52
article thumbnail

Record Shingrix sales help GSK raise 2022 forecasts

pharmaphorum

In its first set of financial figures since spinning off its consumer health division, GSK has reported a 19% increase in revenues, driven by burgeoning demand for its shingles vaccine Shingrix, which has helped the company to raise its full-year guidance. Total revenues came in at £6.9 billion ($8.3 billion) – ahead of forecasts – although costs associated with the separation of consumer health unit Haleon as a separately listed company contributed to a 35% decline in operating profit to £1.1 b

article thumbnail

Robotics hiring levels in the pharmaceutical industry rose in June 2022

Pharmaceutical Technology

The proportion of pharmaceutical companies hiring for robotics related positions rose in June 2022 compared with the equivalent month last year, with 21.3% of the companies included in our analysis recruiting for at least one such position. This latest figure was higher than the 17.2% of companies who were hiring for robotics related jobs a year ago and an increase compared to the figure of 21.1% in May 2022.

article thumbnail

Sanofi Partners With Howard University

PharmExec

Howard University College of Pharmacy will now offer a two-year post-professional Doctorate in Pharmacy fellowship program.

52
article thumbnail

EC grants approval for AbbVie’s Rinvoq to treat ulcerative colitis in adults

Pharmaceutical Technology

The European Commission (EC) has granted approval for AbbVie ’s Rinvoq (upadacitinib) to treat moderate-to-severe active ulcerative colitis (UC) in adult patients. Treatment with upadacitinib 45mg (induction dose) and 15mg and 30mg (maintenance doses) are indicated for UC patients who have had an insufficient, lost response or were not tolerant to either standard therapy or a biologic agent.

article thumbnail

Daily OTC Pearl: Simethicone

Pharmacy Times

Simethicone helps with relief of gas, pressure, and bloating.

65